FDA Inspection 1303434 — Thomas P. Uncini, M.D.
The FDA completed an inspection of Thomas P. Uncini, M.D. on Feb 12, 2026 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 12, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Minneapolis, MN (United States)
Additional details
Clinical Investigator (CI)